clomipramine has been researched along with paroxetine in 98 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (10.20) | 18.7374 |
| 1990's | 37 (37.76) | 18.2507 |
| 2000's | 33 (33.67) | 29.6817 |
| 2010's | 14 (14.29) | 24.3611 |
| 2020's | 4 (4.08) | 2.80 |
| Authors | Studies |
|---|---|
| Blakely, RD; Groshan, K; Richelson, E; Tatsumi, M | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Artursson, P; Mateus, A; Matsson, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alonso, C; Campillo, NE; Cuesta-Geijo, MÁ; Delgado, R; Gil, C; Ginex, T; Morales-Tenorio, M; Muñoz-Fontela, C | 1 |
| Chen, W; Han, S; Hu, Y; Li, H; Tong, X; Yang, L; Zuo, J | 1 |
| Artigas, F; Ortiz, J | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Clissold, SP; Dechant, KL | 1 |
| Bech, P; Bjerrum, H; Butler, B; Bøjholm, S; Folker, H; Gram, LF; Larsen, JK; Lauritzen, L; Loldrup, D; Møller, SE | 1 |
| Insel, TR; Winslow, JT | 1 |
| Mellerup, ET; Plenge, P | 1 |
| Andersson, A; Bäckström, I; Marcusson, JO | 1 |
| Fourie, J; Gagiano, CA; Le Roux, JF; Müller, PG | 1 |
| Archambault, JC; Chabannes, JP; Clerc, G; Desvilles, M; Guibert, M; Guillibert, E; Pagot, R; Pelicier, Y; Poisat, JL; Thobie, Y | 1 |
| Fuller, RW | 1 |
| Briley, M; Moret, C | 1 |
| Mellerup, ET; Plenge, P; Rafaelsen, OJ | 1 |
| Graham, D; Langer, SZ; Tahraoui, L | 1 |
| Ishikura, Y; Ono, H; Yokota, S | 1 |
| Eriksson, K; Marcusson, J | 1 |
| Lassen, JB; Lund, J; Søndergaard, I | 1 |
| Blackburn, TP; de Biasi, V; Kennett, GA; Lightowler, S; Stevens, NC; Tulloch, IF; Wood, MD | 1 |
| Althof, SE | 1 |
| Deltito, JA | 1 |
| Buchholtz-Hansen, PE; Kragh-Sørensen, P; Wang, AG | 1 |
| Balon, R | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Bell, CJ; Coupland, NJ; Potokar, JP | 1 |
| Judge, R; Zohar, J | 1 |
| Harnett-Sheehan, K; Sheehan, DV | 1 |
| Bakker, A; Dunbar, G; Judge, R; Lecrubier, Y | 1 |
| Judge, R; Lecrubier, Y | 1 |
| Rey, JM; Wever, C | 1 |
| Bray, J; Hunter, BN; Judge, R; Morton, NH; Ravindran, AV | 1 |
| Gartside, SE; Sharp, T; Umbers, V | 1 |
| Ishigooka, J; Kasahara, T; Miura, S; Murasaki, M; Nagata, E | 1 |
| Bovier, P; Karege, F; Malafosse, A; Stepanian, R | 1 |
| Stein, MB | 1 |
| Davidson, JR | 1 |
| Altamura, AC; Bignotti, S; Curreli, R; Pioli, R; Tura, G | 1 |
| Brøsen, K; Skjelbo, EF | 1 |
| Pigott, TA; Seay, SM | 1 |
| Bakker, A; Matser, D; Spinhoven, P; van Balkom, AJ; van Dyck, R | 1 |
| Boyer, P | 1 |
| Salama, AA; Salama, SA | 1 |
| McAllister-Williams, RH; Porter, RJ; Young, AH | 1 |
| Alvarez, JC; Arnulf, I; Gluck, N; Launay, JM; Leboyer, M; Pecquery, R; Perez-Diaz, F; Quintin, P; Spreux-Varoquaux, O | 1 |
| Bakker, A; Spinhoven, P; van Balkom, AJ; van Dyck, R | 1 |
| McMahon, CG; Samali, R | 1 |
| Antonietti, M; Denis, P; Ducrotte, P; Lalaude, O; Leroi, AM; Menard, JF; Touchais, JY | 1 |
| Han, JH; Kim, SC; Lee, MY; Seo, KK | 1 |
| Akiskal, HS; Frare, F; Mata, B; Mengali, F; Perugi, G; Recchia, M; Serra, G; Toni, C; Vitale, B | 1 |
| Abdel-Hamid, IA; El Gilany, AH; El Naggar, EA | 1 |
| Kim, SC; Lee, MY; Seo, KK | 1 |
| Bellodi, L; Cavallini, MC; Cavedini, P; Diaferia, G; Erzegovesi, S; Locatelli, M | 1 |
| Feroli, S; Heyden, A; Kerwin, RW; Lovestone, S; Makoff, A; Miller, AH; Pariante, CM | 1 |
| Fujishiro, J; Imanishi, T; Onozawa, K; Tsushima, M | 1 |
| Braconnier, A; Cohen, D; Le Coent, R | 1 |
| Ohmori, T; Sumitani, S | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH | 2 |
| Kim, SW; Lee, SH; Paick, JS | 1 |
| Olivier, B; Waldinger, MD; Zwinderman, AH | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Roth, M; Schulze, U; Strobel, M; Warnke, A | 1 |
| Owen, JC; Whitton, PS | 1 |
| Azuma, N; Fujii, Y; Kamei, C; Kitazumi, K; Shinomiya, K; Sugimoto, Y; Tokunaga, S | 1 |
| Källén, B; Otterblad Olausson, P | 1 |
| Corace, E; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Garcia, CS | 1 |
| Rybakowski, JK; Łojko, D | 1 |
| Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
| Bakker, A; Dusseldorp, E; Spinhoven, P; van Balkom, AJ; van Dyck, R | 1 |
| Drago, F; Leggio, GM; Micale, V | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Holman, JR; Kimmer, SL; Lo, V; Mercado, MG; Wanserski, G | 1 |
| Baharav, E; Bar, M; Gil-Ad, I; Grunbaum-Novak, N; Korob, I; Lomnitski, L; Taler, M; Weizman, A | 1 |
| Funato, H; Hobara, T; Matsubara, T; Matsuo, K; Otsuki, K; Suetsugi, M; Uchida, S; Watanabe, Y | 1 |
| Aubry, JM; Bertschy, G; Bondolfi, G; Gex-Fabry, M; Kosel, M; Malafosse, A; Perroud, N; Uher, R | 1 |
| Bejerot, S; Engström, I; Humble, MB; Uvnäs-Moberg, K | 1 |
| Auffret, M; Bastides, M; Béné, J; Gautier, S | 1 |
| Dao-Ung, P; Fuller, SJ; Skarratt, KK; Stokes, L | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Choudhary, MI; Jabeen, A; Rahman, N; Sheikh, S; Zafar, H | 1 |
| Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
18 review(s) available for clomipramine and paroxetine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction.
Topics: Antibodies; Ebolavirus; Glycoproteins; Hemorrhagic Fever, Ebola; Humans; Molecular Docking Simulation; Niemann-Pick C1 Protein; Protein Binding; Small Molecule Libraries; Virus Internalization | 2021 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Topics: Amitriptyline; Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Drug Evaluation; Drug Tolerance; Humans; Imipramine; Paroxetine; Piperidines; Serotonin Antagonists | 1991 |
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Antidepressants in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Psychotherapy; Sertraline; Sexual Dysfunctions, Psychological | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Medication treatments for panic disorder and social phobia.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders | 1998 |
The long-term treatment of panic disorder.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine; Cognitive Behavioral Therapy; Drug Administration Schedule; Follow-Up Studies; Humans; Long-Term Care; Panic Disorder; Paroxetine; Recurrence; Relaxation Therapy; Treatment Outcome | 1998 |
A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Pharmacological treatment of premature ejaculation.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Dysfunction, Physiological | 1999 |
[The treatment of OCD].
Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Drug Therapy, Combination; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors | 2003 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Ejaculation; Humans; Male; Paroxetine; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Single-Blind Method; Surveys and Questionnaires; Sympatholytics | 2004 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
21 trial(s) available for clomipramine and paroxetine
| Article | Year |
|---|---|
Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression.
Topics: Adult; Aged; Amino Acids; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Serotonin Antagonists; Tryptophan | 1990 |
Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists | 1990 |
The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
Topics: Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists | 1989 |
A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
Topics: Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists | 1989 |
Mortality in major affective disorder: relationship to subtype of depression. The Danish University Antidepressant Group.
Topics: Adult; Aged; Citalopram; Clomipramine; Denmark; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Suicide | 1993 |
Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1996 |
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1997 |
Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Long-Term Care; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1997 |
A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anxiety Disorders; Clomipramine; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Headache; Humans; Middle Aged; Nausea; Paroxetine; Patient Dropouts; Placebos; Primary Health Care; Psychiatric Status Rating Scales; Sweating; Treatment Outcome; Tremor; Xerostomia | 1997 |
The effect of clinical outcome on platelet G proteins of major depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Blotting, Western; Clomipramine; Depressive Disorder; Female; GTP-Binding Proteins; Humans; Imipramine; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Signal Transduction; Treatment Outcome | 1998 |
Double-blindness procedure did not mask giving of medication in panic disorder.
Topics: Clomipramine; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers.
Topics: Adolescent; Adult; Area Under Curve; Clomipramine; Cyclohexanols; Human Growth Hormone; Humans; Male; Nausea; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Tryptophan; Venlafaxine Hydrochloride; Vomiting | 1999 |
Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
Topics: Adolescent; Adult; Aged; Agoraphobia; Clomipramine; Cognitive Behavioral Therapy; Comorbidity; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome | 1999 |
A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
Topics: Adult; Aged; Agoraphobia; Antidepressive Agents; Clomipramine; Demography; Female; Humans; Imipramine; Italy; Longitudinal Studies; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Probability; Prospective Studies; Time Factors; Treatment Outcome | 2000 |
Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation.
Topics: Adult; Antidepressive Agents; Clomipramine; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Paroxetine; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sertraline; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Time Factors | 2001 |
Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Child; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Logistic Models; Male; Paroxetine; Patient Compliance; Safety; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric | 2003 |
On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Clomipramine; Cluster Analysis; Coitus; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?
Topics: Adolescent; Adult; Antidepressive Agents; Clomipramine; Cognitive Behavioral Therapy; Female; Humans; Internal-External Control; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Regression Analysis; Treatment Outcome | 2007 |
Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.
Topics: Adolescent; Adult; Clomipramine; Double-Blind Method; Humans; Middle Aged; Obsessive-Compulsive Disorder; Oxytocin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2013 |
59 other study(ies) available for clomipramine and paroxetine
| Article | Year |
|---|---|
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
Topics: Antidepressive Agents; Brain; Carrier Proteins; Cell Line; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Symporters; Synaptosomes | 1997 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Discovery of potent ebola entry inhibitors with (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold.
Topics: Antiviral Agents; Ebolavirus; Hemorrhagic Fever, Ebola; HIV Fusion Inhibitors; Humans; Molecular Docking Simulation; Virus Internalization | 2022 |
Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.
Topics: Animals; Biological Transport, Active; Blood Platelets; Clomipramine; Endothelium, Vascular; Fluoxetine; Lung; Male; Paroxetine; Piperidines; Plasma; Rats; Rats, Inbred Strains; Serotonin | 1992 |
Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups.
Topics: Animals; Body Temperature; Catecholamines; Citalopram; Clomipramine; Desipramine; Flumazenil; Mazindol; Motor Activity; Naltrexone; Nortriptyline; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stress, Psychological; Ultrasonics; Vocalization, Animal | 1990 |
Why some depressed patients may have low platelet 3H-imipramine binding.
Topics: Antidepressive Agents; Blood Platelets; Carrier Proteins; Cell Membrane; Clomipramine; Depressive Disorder; Humans; Imipramine; Paroxetine; Piperidines; Receptors, Drug; Receptors, Neurotransmitter; Serotonin Antagonists | 1990 |
Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.
Topics: Aged; Animals; Antidepressive Agents; Binding Sites; Brain; Citalopram; Clomipramine; Humans; In Vitro Techniques; Male; Middle Aged; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1989 |
High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
Topics: Amitriptyline; Animals; Citalopram; Clomipramine; Cyclopropanes; Hypothalamus; Imipramine; Kinetics; Male; Milnacipran; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium | 1986 |
Chlorimipramine--but not imipramine--rapidly reduces imipramine--but not paroxetine--binding in human platelets.
Topics: Blood Platelets; Clomipramine; Humans; Imipramine; Iodine; Paroxetine; Piperidines; Serotonin; Tritium | 1986 |
Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
Topics: Animals; Cerebral Cortex; Citalopram; Clomipramine; Clorgyline; Kinetics; Male; Membranes; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Selegiline; Serotonin | 1987 |
Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine.
Topics: Amitriptyline; Anesthesia; Animals; Antidepressive Agents; Atrioventricular Node; Blood Pressure; Clomipramine; Dogs; Electrocardiography; Female; Heart Conduction System; Heart Rate; Hemodynamics; Imipramine; Male; Paroxetine; Piperidines; Respiration | 1987 |
Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
Topics: Animals; Brain; Cell Membrane; Citalopram; Clomipramine; Imipramine; Kinetics; Male; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Zimeldine | 1988 |
Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
Topics: Animals; Anisoles; Brain; Clomipramine; Diet; Dioxolanes; Female; Male; Motor Activity; p-Chloroamphetamine; Paroxetine; Piperidines; Rats; Serotonin; Serotonin Antagonists | 1980 |
Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.
Topics: Animals; Brain; Clomipramine; Desipramine; Fluoxetine; Male; Motor Activity; Norepinephrine; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Time Factors | 1994 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid | 1994 |
Serotonin reuptake inhibitor withdrawal.
Topics: 1-Naphthylamine; Adolescent; Adult; Age Factors; Clomipramine; Dizziness; Female; Fluvoxamine; Humans; Male; Middle Aged; Paresthesia; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Substance Withdrawal Syndrome | 1996 |
Juvenile obsessive-compulsive disorder.
Topics: Adolescent; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Personality Assessment; Prognosis; Treatment Outcome | 1997 |
Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Amitriptyline; Animals; Clomipramine; Cyclohexanols; Male; Neurons; Paroxetine; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 1997 |
Effects of washing procedure on platelets pretreated with serotonin uptake inhibitors in vitro: low Ki values predict long-lasting inhibition of serotonin uptake in vivo.
Topics: Antidepressive Agents; Binding Sites; Blood Platelets; Cells, Cultured; Clomipramine; Depression, Chemical; Duloxetine Hydrochloride; Humans; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes | 1998 |
Depressive symptomatology during clozapine treatment: two case reports.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Clozapine; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Schizophrenia | 1998 |
[Interaction between paroxetine and clomipramine as a possible reason for admission to a department of internal medicine].
Topics: Aged; Antidepressive Agents, Tricyclic; Clomipramine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dizziness; Drug Interactions; Female; Genotype; Hospitalization; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1998 |
[Proofs of efficacy].
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
New behavioral approach to trichotillomania.
Topics: Adolescent; Adult; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Trichotillomania | 1999 |
Citalopram: new indication. No advantage.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1999 |
Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Case-Control Studies; Clomipramine; Depressive Disorder; Female; Fluoxetine; Humans; Inositol 1,4,5-Trisphosphate; Male; Middle Aged; Paroxetine; Platelet Aggregation; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Time Factors | 1999 |
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cathartics; Cholinergic Antagonists; Clomipramine; Colon; Colonoscopy; Constipation; Depressive Disorder; Eating; Fecal Impaction; Female; Gastrointestinal Motility; Humans; Male; Manometry; Maprotiline; Middle Aged; Mood Disorders; Muscle Contraction; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thiazepines; Viloxazine | 2000 |
Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2000 |
Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Humans; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2001 |
Clinical predictors of drug response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Citalopram; Clomipramine; Drug Resistance; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychological Tests; Random Allocation; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters.
Topics: Animals; Antidepressive Agents; Calcium Channel Blockers; Cell Line; Chloramphenicol O-Acetyltransferase; Clomipramine; Corticosterone; Dexamethasone; Glucocorticoids; Hydrocortisone; In Vitro Techniques; Paroxetine; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Transcription, Genetic; Verapamil | 2001 |
Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Cholinergic Antagonists; Clomipramine; Defecation; Fluvoxamine; Immobilization; Mice; Mice, Inbred ICR; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2002 |
In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Hypogastric Plexus; In Vitro Techniques; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Seminal Vesicles; Serotonin; Sertraline; Vas Deferens | 2004 |
[Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Topics: Adolescent; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Clomipramine; Depressive Disorder; Female; Follow-Up Studies; Humans; Length of Stay; Outcome Assessment, Health Care; Paroxetine; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats.
Topics: Amantadine; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Clomipramine; Drug Synergism; Male; Microdialysis; Paroxetine; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Serotonin | 2005 |
Effect of paroxetine on marble-burying behavior in mice.
Topics: Animals; Clomipramine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2005 |
Antidepressant drugs during pregnancy and infant congenital heart defect.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Clomipramine; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Sweden | 2006 |
Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.
Topics: Adult; Alprazolam; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Clomipramine; Drug Eruptions; Female; Food-Drug Interactions; Gadus morhua; Humans; Hypnotics and Sedatives; Meat; Obsessive-Compulsive Disorder; Paroxetine; Urticaria | 2006 |
L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Treatment Outcome | 2007 |
The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men.
Topics: Adult; Benzylamines; Clomipramine; Cohort Studies; Coitus; Dose-Response Relationship, Drug; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Netherlands; Paroxetine; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Tramadol; Treatment Outcome | 2007 |
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Motor Activity; Paroxetine; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Swimming | 2008 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Clinical inquiries. What's the best drug treatment for premature ejaculation?
Topics: Anesthetics, Local; Antidepressive Agents; Clomipramine; Ejaculation; Fluoxetine; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Paroxetine; Phosphodiesterase Inhibitors; Prilocaine; Sertraline; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders.
Topics: Animals; Antidepressive Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Clomipramine; Cyclooxygenase 2; Female; Immune System Diseases; Lymphocyte Activation; Lymphocytes; Mitogen-Activated Protein Kinases; Paroxetine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred Lew; Sertraline; Spleen; Tumor Necrosis Factor-alpha | 2008 |
Altered gene expression of histone deacetylases in mood disorder patients.
Topics: Animals; Antidepressive Agents; Clomipramine; Corticotropin-Releasing Hormone; Dexamethasone; Disease Models, Animal; Female; Gene Expression Regulation; Histone Deacetylases; Humans; Hydrocortisone; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Mood Disorders; Paroxetine; RNA, Messenger; Swimming | 2010 |
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Genetic Association Studies; Humans; Male; Middle Aged; Paroxetine; Piperazines; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1B; Severity of Illness Index; Suicidal Ideation; Tacrolimus Binding Proteins; Triazoles; Venlafaxine Hydrochloride; Young Adult | 2011 |
Serotonin and yawning: A possible adverse drug reaction during antidepressant therapy.
Topics: Antidepressive Agents; Clomipramine; Drug-Related Side Effects and Adverse Reactions; Humans; Paroxetine; Serotonin; Yawning | 2014 |
Paroxetine suppresses recombinant human P2X7 responses.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Humans; Interleukin-1beta; Lipopolysaccharide Receptors; Mice; Monocytes; Paroxetine; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Recombinant Proteins; Trifluoperazine | 2015 |
Drug repurposing for the identification of new Bcl-2 inhibitors: In vitro, STD-NMR, molecular docking, and dynamic simulation studies.
Topics: Antineoplastic Agents; Carvedilol; Cell Line, Tumor; Citrates; Clomiphene; Clomipramine; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Molecular Dynamics Simulation; Paroxetine; Proto-Oncogene Proteins c-bcl-2 | 2023 |